Company behind ‘digital pill’ with embedded chip raises $62.5M

Gigaom

Forgetting whether you took your meds will be a thing of the past if Proteus Digital Health has its way.  Last year, the Redwood, Calif. company received FDA clearance for a “digital pill” that tracks whether patients are taking their medication and how their bodies are responding to it. On Wednesday, Proteus said it had raised an additional $62.5 million to help bring its product to market.

The company said the second closing of its Series F round (it closed the first round in December) included new investor, database giant Oracle(s orcl), as well as previous investors Otsuko, Novartis, Sino Portfolio and others.

Proteus declined to comment on the new funding but, in a statement, CEO Andrew Thompson said the company is looking to its strategic partners to help accelerate its mission by embedding Proteus into already established products and services.

Since launching in 2003, the company has raised north of $100…

View original post 240 more words

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: